Truncation of the amino-terminus of the recombinant aggrecan rAgg1mut leads to reduced cleavage at the aggrecanase site.: Efficient aggrecanase catabolism may depend on multiple substrate interactions
- 30 November 2000
- journal article
- Published by Elsevier in Matrix Biology
- Vol. 19 (6), 533-543
- https://doi.org/10.1016/s0945-053x(00)00113-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS FamilyJournal of Biological Chemistry, 1999
- Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the ‘aggrecanase’ and the MMP sitesBiochemical Journal, 1998
- Utilization of a Recombinant Substrate rAgg1 to Study the Biochemical Properties of Aggrecanase in Cell Culture SystemsPublished by Elsevier ,1997
- Expression OF membrane type 1 matrix metalloproteinase in human articular cartilageArthritis & Rheumatism, 1997
- Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.Journal of Clinical Investigation, 1996
- Chondrocyte Matrix Metalloproteinase-8: HUMAN ARTICULAR CHONDROCYTES EXPRESS NEUTROPHIL COLLAGENASEPublished by Elsevier ,1996
- Degradation of cartilage aggrecan by collagenase‐3 (MMP‐13)FEBS Letters, 1996
- Monoclonal antibodies that specifically recognize neoepitope sequences generated by ‘aggrecanase’ and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitroBiochemical Journal, 1995
- Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domainBiochemical Journal, 1993
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990